WOLHUSEN, Switzerland: Last week, Geistlich Pharma announced that Diego Gabathuler is the company’s new CEO. An experienced leader and expert in the medical technology industry, the 49-year-old Swiss will guide Geistlich’s expansion strategy in the field of regenerative medicine. Earlier this year, Gabathuler resigned as CEO of Ivoclar after nearly four years in that position. Gabathuler succeeds Dr Ralf Halbach, who left the company in August after almost two years in order to seek new professional challenges.